Silencing in Biological Technology
Navigation Links
Silencing in Biological Technology
Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
... School will present on "Complexity of RNA silencing in C. elegans." Both scientists shared the 2006 ... the world working in different branches of RNA silencing to share their findings and facilitate a deeper ... complexity of small RNA-related phenomena. RNA silencing pathways control an ever-expanding range of ...Lentigen Licenses Fundamental Lentiviral Vector Technology Patent From the University of Cambridge
... vehicles for stable delivery of genes or gene silencing sequences (e.g. RNAi) into cells. Gene delivery ... The LV genomic RNA comprising the gene or gene silencing sequence is then converted to DNA and permanently ... extraordinary high efficiency. The gene or gene silencing sequence is then expressed in the cells, ...Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
... of normal cell survival and aberrant gene silencing in cancer cells. Inhibition of sirtuins allows ... emerged as a key contributor to the epigenetic silencing of genes that drive tumorigenesis," said Stephen ... reversed by targeting the enzymes involved. The silencing of key cell cycle control genes and ...Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
... as generation of stably-transformed cell lines in 28-days, as well as gene silencing and RNAi services (http://www.altogen.com/support.htm ). About Altogen ... pharmaceutical services, including generation of stable cell lines, gene silencing and RNA Interference (RNAi) services, assay development, library ...Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA
... targets small interfering RNA (siRNA), likely within the RNA-induced silencing complex (RISC) of the RNA interference (RNAi) mechanism. The paper is ... at New York Medical College and Alfacell. The study demonstrated that silencing the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene (an abundant ...... to the target cell membrane. The LV RNA containing the gene or gene silencing sequence is then incorporated into the cell via reverse transcription ... vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, ...
... research. RNAi plays a multifaceted role in molecular biology by silencing genes through chromatin remodeling, interfering with protein synthesis, ... of the structure and function of small interfering RNA including their silencing properties and complex interplay with the targeted sequences inside ...
Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
... research. RNAi plays a multifaceted role in molecular biology by silencing genes through chromatin remodeling, interfering with protein synthesis, ... of the structure and function of small interfering RNA including their silencing properties and complex interplay with the targeted sequences inside ...Benitec MOU With CalbaTech, Inc.
... a license agreement with Benitec, an Australian corporation. Gene silencing Gene silencing is about controlling the flow of genetic information. Our genome operates ...Sirnaomics Receives SBIR Grant from NIH/NCI for Its Multi-Targeted Lung Cancer siRNA Therapeutics
... important biological phenomenon and as a versatile, powerful tool for biomedical research. RNAi plays a multifaceted role in molecular biology by silencing genes through chromatin remodeling, interfering with protein synthesis, and in its best-studied mode of action quashing gene expression by cleaving ...... high transfection efficiency and viability in biologically relevant cell types. Cellaxess(R)HT will allow us to undertake ambitious expression and silencing screening projects that would have been both economically and practically unfeasible with conventional instrumentation." Purchase of the ...
Roche Madison Moves to New Facility
... of a major new class of medicines, known as RNAi therapeutics, is on the horizon. RNAi therapeutics targets the cause of diseases by potently silencing specific messenger RNAs (mRNAs), thereby preventing disease-causing proteins from being made. RNAi therapeutics has the potential to treat disease ...... technologies for stem cell research includes the industry's most highly-validated shRNA library, the MISSION(R) RNAi portfolio, which enables gene silencing across a wide range of cellular targets. The site also features the CompoZrTM zinc finger nuclease (ZFN) reagent platform which enables researchers, ...
Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing Lentiviral vector-based products across a broad spectrum of ...... Professor of Biochemistry & Molecular Pharmacology at University of Massachusetts Medical School , generally claims methods of enhancing the RNA silencing activity of an RNAi agent through certain structural modifications in various cell types, including mammalian. The issued claims not only focus on ...
Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics
... important biological phenomenon and as a versatile, powerful tool for biomedical research. RNAi plays a multifaceted role in molecular biology by silencing genes through chromatin remodeling, interfering with protein synthesis, and in its best-studied mode of action quashing gene expression by cleaving ...Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
... targets for siRNA therapeutic development. A third poster, submitted by Hagit Ashush, is titled "Tandem and RNAstar molecules for simultaneous silencing several genes," and evaluates the potential of complex dsRNA structures targeting two ("tandem") or three ("RNAstar") different genes in vitro. The ...Lentigen Corporation Announces Relocation to New Facility
... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of ...Lentigen Appoints Jim Meade as Vice President of Corporate Development
... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of ...Lentigen Corporation Receives Four Research Grants From the National Institutes of Health
... vaccine and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of ...... . About OPKO Health, Inc. Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the pioneering gene silencing agent bevasiranib, has entered a pivotal Phase III trial after successfully completing Phase II trials for wet age-related macular degeneration and ...
Lentigen to Move Headquarters and Manufacturing to Gaithersburg
... vaccine and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing lentiviral vector-based products across a broad spectrum of ...... gene expression. Epigenetic changes can silence gene expression and, unlike DNA mutations, may be reversed by targeting the mechanisms involved. The silencing of key cell cycle control genes and tumor suppressor genes through these two mechanisms of epigenetic regulation has been demonstrated in vitro and ...
Progen Expands Drug Development Pipeline Through Acquisition of CellGate
... technologies in the areas of epigenetics and polyamines that will form the foundation for new compound development. Epigenetics, or the silencing of cancer related gene expression, is becoming a well-defined target in oncology and Progen is excited to be entering this new frontier of cancer ...Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
... and research applications in biotechnology and medicine. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing Lentiviral vector-based products across a broad spectrum of ...Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
... regimen, as compared with current first line treatment. The acquisition also provides Amarin with access to a platform messenger RNA (mRNA) silencing technology which targets the cholinergic pathway, and a promising preclinical program in neurodegeneration and inflammation. Amarin also ...VIRxSYS and Lentigen Announce Litigation Settlement
... a wide range of applications in biotechnology and medicine. Lentiviral vectors are highly adapted delivery vehicles that can transport genes or gene silencing sequences into cells with high efficiency and stability. Lentigen is positioning itself to become the leading provider of lentiviral vector products ...Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million
... a wide range of applications in biotechnology and medicine. Lentiviral vectors are highly adapted delivery vehicles that can transport genes or gene silencing sequences into cells with high efficiency and stability. Lentigen is positioning itself to become the leading company for the development of ...Amarin Signs Agreement to Acquire Ester Neurosciences
... initial consideration is $15 million, plus up to $17 million in contingent payments. Ester's core assets include (i) a platform messenger RNA (mRNA) silencing technology which targets the cholinergic pathway; (ii) EN101, a Phase II compound with promising efficacy data for the treatment of myasthenia gravis ...OPKO Health Acquires Rights to Clinical Stage Compound for Dry Eye
... often ineffective. About OPKO Health, Inc. Miami-based OPKO is a specialty healthcare company. Its lead investigational drug, the pioneering gene silencing agent bevasiranib, has entered a pivotal Phase III trial after successfully completing Phase II trials for wet age-related macular degeneration and ...Biotech Hall of Fame Inductees Announced
... Z. Fire and Craig C. Mello Co-recipients of the 2006 Nobel Prize in Physiology or Medicine for their discovery of RNA interference -- gene silencing by double-stranded RNA. RNA interference occurs in plants, animals, and humans. It is of great importance for the regulation of gene ...Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics
... (mRNA) for degradation. The most common RNAi agents are double-stranded RNAs, which ultimately associate with proteins to form an RNA-induced silencing complex (RISC). The antisense RNA within active RISC binds to its mRNA target, which is then cleaved and degraded by the RNase enzyme in the complex. ...Team demos safety of RNA therapy
... not have the same toxic effects as large doses of shRNA because it does not interfere with the microRNA pathway. Further, they achieved 80 percent silencing of target genes in mice and hamster liver cells. Using chemically synthesized siRNA, you can deliver sufficient siRNA to achieve therapeutically ...Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
... of gene expression. Epigenetic changes can silence gene expression and, unlike DNA mutations, may be reversed by targeting the enzymes involved. The silencing of key cell cycle control genes and tumor suppressor genes through these two mechanisms of epigenetic regulation have been demonstrated in vitro and ...Mirus Bio Awarded Grants & Contracts of Over $5 Million
... systemic delivery of small interfering RNA (siRNA), a molecule that triggers a natural cellular process called RNA interference. By selectively silencing the expression of a gene, one can prevent the production of disease-causing proteins. DPCs are comprised of proprietary polymers, masking agents and ...Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit
... In general, we obtain a maximum silencing effect with a final concentration of 10 nM ... Figure 1A shows that the same powerful silencing effect was obtained with both labeled ... Pab 1, was not affected (Figure 1A). The specific silencing of hrp48 and U2AF 50 proteins was ...RNA Interference and Gene Silencing: History and Overview
... May 20, 2002 Post-transcriptional gene silencing (PTGS), which was initially considered a ... and has roles in viral defense and transposon silencing mechanisms. Perhaps most exciting, ... ). But what causes this gene silencing effect? Although ...Your Data: Silencing of a Pro-apoptotic Transcription Factor Using Synthetic siRNA
... One of the RNA silencing products available from Ambion is ... siRNA mediated gene silencing studies were carried out to assess the ... neural stem cell differentiation. silencing of Gadd153, a pro-apoptotic transcription factor, ...Visualizing siRNA in Mammalian Cells: Fluorescence Analysis of the RNAi Effect
... or Cy3 was demonstrated to have no effect on silencing efficiency, but allowed visualization ... labeled siRNA, the time course of gene silencing was examined at both the mRNA and protein level. ... 10 days post transfection. The initiation of the silencing effect was found to correlate well ...Other ContentscompositecompositecompositecompositecompositecompositecomplementationcomplementationcompletecompletecompletecompletecompletecompletecompletecompletecompletecompletecompoundcompoundcompoundcompoundcompoundcompoundcompoundcompoundcompoundcomputationalcomputationalcomputationalcomputationalcomputationalconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconcentrationconeconeconeconeconeOther TagsCyclinCyclinMemberMemberOther Tagsalarmed 2enjoying 2enjoying 3background 2background 3background 4background 5background 6background 7background 8background 9background 10racial 2racial 3racial 4racial 5pigs 2practices 2practices 3practices 4
(Date:11/24/2009)...le in Spanish . , The presence of increased...tory substances in the blood, hinders the loss and...h project of the University of Navarra conducted b...ool of Pharmacy. , The project, entitled "A nutr... control of body weight and inflammation," examine...
(Date:11/23/2009)...2009 - The time of day matters to forest trees dea...ed by a research team led by Professor Malcolm Cam...incipal for research and colleagues in the departm...campus. , Capitalizing on their previous work ...rch team examined how poplar trees use their 45,00...
(Date:11/23/2009)... study provides "incontrovertible evidence" that t...f Sumatra about 73,000 years ago deforested much o...er, researchers report. , The volcano ejected an...mosphere, leaving a crater (now the world,s larges...5 kilometers wide. Ash from the event has been fou...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Allied Worlds Susan Chmieleski to Participate in Hospital Management Asia 2009 Conference 54129 1Allied Worlds Susan Chmieleski to Participate in Hospital Management Asia 2009 Conference 54129 2Allied Worlds Susan Chmieleski to Participate in Hospital Management Asia 2009 Conference 54129 3APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services 54126 1APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services 54126 2APTA Calls For CMS and Congressional Action to Prohibit Unqualified Personnel From Providing Physical Therapy Services 54126 3PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 1PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 2PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 3PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 4PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 5PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 6PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 7PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 8PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 9PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 10PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 11PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 12PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 13PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 14PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 15PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 16PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results 54123 17(Date:11/27/2009)...w-emission vehicles may reduce future disease burd...(HealthDay News) -- Encouraging city dwellers to w...much greater public health benefits than increased...ave found. , The study compared the projected h...ansport scenarios for London, England, and Delhi, ...
(Date:11/27/2009)...ulti-purpose bilingual coloring books designed for...siness community to educate - inform parents and c... issues to Dinosuars to ABC,S and a host of other ... (PRWEB) November 27, 2009 -- Today’s childr...p them busy any hour of the day, but one of the ol...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2[0] More Foot Power, Less Car Pollution Best for Health[2] Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books [1] Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows[0] Watching the Nail-Biting Big Game Hurts So Good[1] Pharmacist Injects Cure for Ailing Businesses
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |